Coloplast A/S Class B COLO_B
OMXCOP · Denmark · Health Technology
DKK 414.10-3.80 (-0.91%)
Market open· · DKK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · DKK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The global ostomy dressings market is projected to grow from USD 3.80 billion in 2026 to USD 4.73 billion by 2031, at a 4.4% CAGR. Growth is driven by rising colorectal cancer and inflammatory bowel disease cases, aging populations, improved peristomal skin care awareness, and expanding home care services. Skin barrier rings will record the fastest product growth, while Asia Pacific will be the fastest-growing region. Key companies include Coloplast, ConvaTec, Hollister, B. Braun, Solventum, and
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/ Kind regards,Investor RelationsColoplast A/STel. +45 4911 1800 For further information, please contact Investors and analystsAnders Lonning-SkovgaardExecutive Vice President, CFOTel. +45 4911 1111 Kristine Husted MunkSenior Director, Investor RelationsTel. +45 4911 1800 / +45 4911 3266Email: [email protected]
Coloplast has been informed that the Danish Financial Supervisory Authority (FSA) has today announced that it has notified Niels Peter Louis-Hansen that it has granted an exemption from the obligation to make a mandatory takeover offer to the shareholders of Coloplast A/S in connection with the contemplated transfer of a controlling indirect ownership interest in Coloplast A/S from NPLH Holding ApS to a non-profit foundation. Reference is made to the Danish Financial Supervisory Authority’s prio
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.